Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Targeting Vδ1+T-cells may help treat alopecia areata.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Interleukin-15 can help hair growth and protect hair follicles.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Exosome-based therapies show promise for treating alopecia areata but need more research.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Gut bacteria differences could help diagnose and treat alopecia areata.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Activating Tgr5 may help treat hair loss and bone loss.

Certain immune markers and vitamin levels could help diagnose alopecia areata.